Aoxing Pharmaceutical Company
Description Aoxing Pharmaceutical Company, Inc., a specialty pharmaceutical company, through its subsidiary, Hebei Aoxing Pharmaceutical Co., Inc., engages in the research, development, manufacture, and distribution of various narcotic, pain-management, and addiction treatment pharmaceutical products in China. The company produces its products in various formulations, such as injection, tablets, capsules, oral solution, and powders. It offers Zhongtongan, a capsule of herbal extraction for the indication of oral and dental pain; Bismuth Potassium Citrate, an oral solution for the treatment of chronic gastritis and stomachache due to excessive stomach acid; Xiaopiling, a granule formulation of herbal extraction to treat fatigue from lack of rest; and Naloxone Hydrochloride, an IV formulation for the treatment of opioid over dosage. The companys products under development include Tilidine hydrochloride, an orally-absorbed synthetic narcotic analgesic for severe pain and chronic cancer-related pain; Codeine Phosphate Compound oral solution for cold and flu treatment; Buprenorphine/Naloxone, a sublingual combo tablet to treat opioid dependence; Tongjingshule capsules for primary Dysmenorrha to treat menstrual pain in adult women; and Oxycodone and Acetaminophen tablets and compound capsules to cure acute and chronic pain. The company was formerly known as China Aoxing Pharmaceutical Company, Inc. and changed its name to Aoxing Pharmaceutical Company, Inc. in March 2010. Aoxing Pharmaceutical Company, Inc. was founded in 1655 and is headquartered in Shijiazhuang, China. To view the detailed information, you need to SUBSCRIBE with us. |
 |